164 related articles for article (PubMed ID: 37129315)
21. Avoidance of primary site adjuvant radiotherapy following transoral robotic surgery: a cohort study.
Fradet L; Charters E; Gao K; Froggatt C; Palme C; Riffat F; Nguyen K; Wu R; Milross C; Clark JR
ANZ J Surg; 2022 Mar; 92(3):511-517. PubMed ID: 35018703
[TBL] [Abstract][Full Text] [Related]
22. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
Smith RV; Schiff BA; Garg M; Haigentz M
Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
[TBL] [Abstract][Full Text] [Related]
23. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer.
Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N
JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238
[TBL] [Abstract][Full Text] [Related]
24. Transoral Surgery in HPV-Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System.
Faraji F; Kumar A; Voora R; Soliman SI; Cherry D; Courtney PT; Finegersh A; Guo T; Cohen E; Califano JA; Mell L; Rose B; Orosco RK
Laryngoscope; 2024 Jan; 134(1):207-214. PubMed ID: 37255050
[TBL] [Abstract][Full Text] [Related]
25. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
[TBL] [Abstract][Full Text] [Related]
26. Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma.
Heah H; Goepfert RP; Hutcheson KA; Garden AS; Gunn GB; Fuller CD; Lewin JS; Kupferman ME; Holsinger FC; Hessel AC; Gross ND
Head Neck; 2018 Nov; 40(11):2507-2513. PubMed ID: 30102824
[TBL] [Abstract][Full Text] [Related]
27. Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma.
Magliocca KR; Kaka AS; Barrow EM; Studer MB; Griffith CC; Ernst J; Meade T; Balicki A; Boyce BJ; Schmitt NC; Bur AM; Schmitt AC; Jackson R; Steuer CE; Beitler JJ; Patel MR
ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):80-87. PubMed ID: 36538901
[TBL] [Abstract][Full Text] [Related]
28. National Trends in 30-Day Readmission Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
Nyirjesy SC; McCrary HC; Zhao S; Judd RT; Farlow JL; Seim NB; Ozer E; Agrawal A; Old MO; Rocco JW; Kang SY; Haring CT
JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):133-141. PubMed ID: 38153724
[TBL] [Abstract][Full Text] [Related]
29. Swallowing Function Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Carcinoma: A 2-Year Follow-up.
Lee E; Gorelik D; Crowder HR; Badger C; Schottler J; Li NW; Siegel R; Sadeghi N; Goodman JF; Thakkar PG; Joshi AS
Otolaryngol Head Neck Surg; 2022 Aug; 167(2):298-304. PubMed ID: 34752157
[TBL] [Abstract][Full Text] [Related]
30. Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
Parhar HS; Weinstein GS; O'Malley BW; Shimunov D; Rassekh CH; Chalian AA; Newman JG; Basu D; Cannady SB; Rajasekaran K; Lin A; Lukens JN; Swisher-McClure S; Cohen RB; Bauml JM; Aggrawal C; Brody RM
Head Neck; 2021 Oct; 43(10):2923-2934. PubMed ID: 34101290
[TBL] [Abstract][Full Text] [Related]
31. A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.
Brody RM; Shimunov D; Cohen RB; Lin A; Lukens JN; Hartner L; Aggarwal C; Duvvuri U; Montone KT; Jalaly JB; LiVolsi VA; Carey RM; Shanti RM; Rajasekaran K; Chalian AA; Rassekh CH; Cannady SB; Newman JG; O'Malley BW; Weinstein GS; Gimotty PA; Basu D
Oral Oncol; 2022 Apr; 127():105798. PubMed ID: 35245888
[TBL] [Abstract][Full Text] [Related]
32. Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6-Year Prospective Registry Analysis.
Anderson BJ; Moreno AC; Qing Y; Lee JJ; Johnson FM; Lango MN; Barbon CEA; Tripuraneni L; Sahli A; Piper V; Gross N; Fuller CD; Lai SY; Myers JN; Hutcheson KA
Otolaryngol Head Neck Surg; 2024 May; 170(5):1319-1330. PubMed ID: 38353360
[TBL] [Abstract][Full Text] [Related]
33. Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population.
Viros Porcuna D; Pollan Guisasola C; Viña Soria C; Cirauqui Cirauqui B; Pardo Muñoz L; Collurá F; Mesia Nin R
Clin Transl Oncol; 2020 Aug; 22(8):1303-1311. PubMed ID: 31858433
[TBL] [Abstract][Full Text] [Related]
34. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
[TBL] [Abstract][Full Text] [Related]
36. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity.
Hemmati M; Barbon C; Mohamed ASR; van Dijk LV; Moreno AC; Gross ND; Goepfert RP; Lai SY; Hutcheson KA; Schaefer AJ; Fuller CD;
Cancer Med; 2023 Feb; 12(4):5088-5098. PubMed ID: 36229990
[TBL] [Abstract][Full Text] [Related]
37. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
[TBL] [Abstract][Full Text] [Related]
38. Transoral surgery alone for human-papillomavirus-associated oropharyngeal squamous cell carcinoma.
Olsen SM; Moore EJ; Laborde RR; Garcia JJ; Janus JR; Price DL; Olsen KD
Ear Nose Throat J; 2013 Feb; 92(2):76-83. PubMed ID: 23460216
[TBL] [Abstract][Full Text] [Related]
39. Predictors of gastrostomy tube dependence in surgically managed oropharyngeal squamous cell carcinoma.
Varma VR; Eskander A; Kang SY; Kumar B; Brown NV; Zhao S; Brock G; Agrawal A; Carrau RL; Old MO; Ozer E; Rocco JW; Schuller DE; Dziegielewski PT; Cipolla MJ; Teknos TN
Laryngoscope; 2019 Feb; 129(2):415-421. PubMed ID: 30194767
[TBL] [Abstract][Full Text] [Related]
40. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
